Skip to the content
09/14/22 Health Advisory: COVID-19 Vaccine Information for Providers
FDA removed its authorization of current (monovalent) Moderna and Pfizer mRNA vaccines for use as booster doses in people 12 years or older. As of Aug. 31, you may no longer give current (monovalent) Moderna and Pfizer vaccines as booster doses to people 12 years or older. Reschedule existing booster dose appointments for people 12 years or older for when bivalent vaccine booster doses are available. You can still give current (monovalent) Moderna and Pfizer vaccines: As booster doses to children 5–11 years old. As a primary series to people 6 months or older. Retain your current vaccine supply and use the vaccine marketplace to shift primary series doses to areas of need.
If possible, it is safe and recommended to administer the bivalent COVID-19 booster at the same time as the seasonal influenza vaccine, given in separate arms. Local healthcare provider offices, local pharmacies, WCHD pop-up vaccine clinics are starting to receive the boosters. On Sept. 1, 2022, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) recommendation of Moderna and Pfizer COVID-19 vaccine bivalent booster doses. Bivalent booster doses enhance immunity against the ancestral coronavirus strain and protect against newer Omicron variants that account for most current cases. Bivalent booster doses provide optimal protection and address waning vaccine effectiveness over time. On Sept. 3, 2022, Western States Scientific Safety Review workgroup concurred with ACIP’s recommendation of bivalent booster doses for people who completed a primary series of COVID-19 vaccine. Washington State Department of Health’s (DOH’s) bivalent booster dose eligibility and recommendations: To receive a bivalent booster dose, a person must first complete a primary series of Pfizer, Moderna, Novavax or Johnson & Johnson COVID-19 vaccine. Pfizer bivalent booster doses are authorized for people 12 years or older, at least 2 months after their most recent dose of COVID-19 vaccine. Moderna bivalent booster doses are authorized for people 18 years or older, at least 2 months after their most recent dose of COVID-19 vaccine. Children 5–11 years old should continue to receive Pfizer monovalent booster doses, at least 5 months after completing their primary series. Booster doses are not authorized for children 6 months–4 years old. Number of booster doses previously received does not affect bivalent booster dose eligibility. We expect DOH to approve statewide standing orders for bivalent booster doses soon. Keep your eye out for notification from DOH. DOH anticipates demand for bivalent booster doses will be greater than supply. Focus early administration on: Preventing severe illness. Minimizing spread of disease. People who live in multigenerational households. People who live or work with people at risk of severe illness. People who live or work in congregate settings. People at higher risk for exposure in their workplace. Protecting communities COVID-19 disproportionately impacts. See health equity strategies from CDC and DOH. Agricultural workers. American Indian. Alaska Native. Asian. Black or African American. Latinx. LGBTQ+. Native Hawaiian. Pacific Islander. People living homeless. People with disabilities. People with limited English proficiency. Slavic or former Soviet Union communities. Food and Drug Administration (FDA) removed its authorization of monovalent mRNA COVID-19 vaccines for booster doses for people 12 years or older. Continue to use Pfizer monovalent COVID-19 vaccine for: Continue to use Moderna monovalent COVID-19 vaccine for: Primary series for people 18 years or older. Wondering what “up-to-date” vaccine status means, now that bivalent booster doses are added to the COVID-19 vaccine schedule? You are up-to-date on COVID-19 vaccine when you have completed a primary series and received the most recent booster dose CDC recommends for you. CDC recommends everyone 12 years or older get a bivalent booster dose at least 2 months after their last dose of COVID-19 vaccine, whether it was a primary series or previous booster dose. Providers who ordered bivalent booster doses will or have received their initial allocation this week. Weekly allocations will follow in upcoming weeks, building the state’s inventory levels over time. If you paused ordering COVID-19 vaccine, we recommend you order bivalent booster doses when they become more available. More resources
How to talk to your patients about COVID-19 vaccine, CDC. Clinical resources for Pfizer COVID-19 vaccine, CDC. Clinical resources for Moderna COVID-19 vaccine, CDC. Clinical resources for Johnson & Johnson COVID-19 vaccine, CDC. COVID-19 isolation and precautions, CDC. Updated COVID-19 vaccination schedule, CDC. Pediatric COVID-19 vaccine toolkit for providers with a variety of resources for providers, like parent handouts and sample communications, Vaccinate WA. COVID-19 guidance for schools and childcare, DOH. COVID-19 vaccine booster doses, DOH. Moderna bivalent COVID-19 vaccine emergency use authorization (EUA), FDA. Pfizer bivalent COVID-19 vaccine EUA, FDA. Our Provider Resources MPV page. MPV page, CDC.
Contact Whatcom County Health and Community Services at 360-778-6100
Contacting The Health Department.
360-778-6100 Main Call Line – available M-F 8:30am to 4:30pm.
Afterhours Answering Service – available after 4:30pm and weekends, call 360-778-6100 and press 2 to be connected to the on-call manager or health officer.
360-778-6150 Communicable Disease Report Line – 24 hours a day 7 days a week
360-778-6103 Confidential Communicable Disease Fax – 24 hours a day 7 days a week
509 Girard Street, Bellingham WA 98225